Document is current
Any future updates will be listed below
-
Authors
Liao, Shufang
Zhang, Bin
Su, Yixin
Pan, Yufei
Zhang, Jian
Ye, Zhenkai
Zhang, Rongjun
Kong, Xiangyun
Qin, Guanjie
Mo, Yunyan
Ruan, Xiaolan
Liu, Jian
Gan, Chunqiao
Dai, Jinxuan
Zhang, Ruyun
Luo, Guanhong
Liao, Xiaofei
Jiang, Wei https://orcid.org/0000-0001-6534-8612
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (No. 82160479)
Natural Science Foundation Key Projects of Guangxi (No. 2018GXNSFDA050021)
the Guangxi Medical and health key discipline construction project (-)
CSCO Youth Innovative Oncology Research Fund (No. Y-Young2020-0520)
Chongzuo City Science and Technology Plan Project (No. 2018012)
Scientific Research Program of the Health Commission of Guangxi Zhuang Autonomous Region (Nos. Z20201200, Z20170816, Z20170207)
- License Information
-
More Information
Article History
Received: 14 June 2023
Accepted: 7 January 2024
First Online: 7 February 2024
Declarations
:
: S. Liao, B. Zhang, Y. Su, Y. Pan, J. Zhang, Z. Ye, R. Zhang, X. Kong, G. Qin, Y. Mo, X. Ruan, J. Liu, C. Gan, J. Dai, R. Zhang, G. Luo, X. Liao, and W. Jiang declare that they have no competing interests.
: The present study was approved by the Ethics Committee of Guangxi of Lingshan County People’s Hospital, the People’s Hospital of Laibin, the People’s Hospital of Guangxi Zhuang Autonomous Region, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Wuzhou Red Cross Hospital, and the affiliated hospital of Guilin Medical University. The study complies with the aims of the Declaration of Helsinki and local laws and was registered with the Chinese Clinical Trials Registry (CliCTR1800017132, 13/07/2018).
